Technical Analysis for PRPH - ProPhase Labs, Inc.

Grade Last Price % Change Price Change
grade B 1.79 -4.95% -0.09
PRPH closed down 4.95 percent on Friday, August 7, 2020, on 9 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Flat Up Up
Historical PRPH trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Upper Bollinger Band Walk Strength 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Narrow Range Bar Range Contraction -4.95%
NR7 Range Contraction -4.95%
Upper Bollinger Band Walk Strength -4.95%
Above Upper BB Strength -4.95%
Overbought Stochastic Strength -4.95%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


ProPhase Labs, Inc. engages in the manufacture, marketing, and distribution of homeopathic and health products to the general public. It is also involved in the research and development of over-the-counter (OTC) drugs, natural base health products with supplements, personal care, and cosmeceutical products. The company offers Cold-EEZE, a zinc gluconate glycine lozenge to reduce the duration and severity of the common cold symptoms. It also markets and distributes two non-lozenge forms of its proprietary zinc gluconate formulation, Cold-EEZE daytime/nighttime QuickMelts and Cold-EEZE oral spray; and Kids-EEZE products for children suffering from upper respiratory infections, allergy, and/or chest congestion, as well as organic cough drops and a Vitamin C supplements. It also provides private label lozenge products for retail customers; and performs contract manufacturing services of cough drop and other OTC cold remedy products for third parties. ProPhase Labs, Inc. sells its products through food, multi-outlet pharmacy and chain drug stores, wholesalers, and mass merchandisers in the United States. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.
Chemistry Health Food Physical Sciences Retail Customers Dietary Supplements Allergy Zinc Contract Manufacturing Services Cough Health Products Over The Counter Drug

Is PRPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 2.59
52 Week Low 1.1
Average Volume 11,737
200-Day Moving Average 1.79
50-Day Moving Average 1.57
20-Day Moving Average 1.68
10-Day Moving Average 1.75
Average True Range 0.09
ADX 38.52
+DI 31.26
-DI 17.34
Chandelier Exit (Long, 3 ATRs ) 1.65
Chandelier Exit (Short, 3 ATRs ) 1.66
Upper Bollinger Band 1.87
Lower Bollinger Band 1.49
Percent B (%b) 0.78
BandWidth 23.08
MACD Line 0.08
MACD Signal Line 0.06
MACD Histogram 0.0187
Fundamentals Value
Market Cap 28.93 Million
Num Shares 16.2 Million
EPS 2.40
Price-to-Earnings (P/E) Ratio 0.75
Price-to-Sales 1.57
Price-to-Book 0.73
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.98
Resistance 3 (R3) 1.99 1.94 1.95
Resistance 2 (R2) 1.94 1.89 1.93 1.94
Resistance 1 (R1) 1.86 1.86 1.84 1.85 1.93
Pivot Point 1.81 1.81 1.80 1.81 1.81
Support 1 (S1) 1.74 1.76 1.71 1.73 1.65
Support 2 (S2) 1.69 1.73 1.68 1.64
Support 3 (S3) 1.61 1.69 1.63
Support 4 (S4) 1.60